Dave Trong Nguyen

Array ( [id] => 1253175 [patent_doc_number] => 06670177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains' [patent_app_type] => B2 [patent_app_number] => 09/043981 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16579 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670177.pdf [firstpage_image] =>[orig_patent_app_number] => 09043981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177351 [patent_doc_number] => 06149903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins' [patent_app_type] => 1 [patent_app_number] => 9/099753 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 34 [patent_no_of_words] => 37979 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149903.pdf [firstpage_image] =>[orig_patent_app_number] => 099753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089194 [patent_doc_number] => 06133245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Antisense DNA constructs for expression of hybrid mRNAs driven by inducible, tissue-specific promoters' [patent_app_type] => 1 [patent_app_number] => 9/096833 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 6970 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133245.pdf [firstpage_image] =>[orig_patent_app_number] => 096833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1110749 [patent_doc_number] => 06806084 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-19 [patent_title] => 'Methods for compositions for in vivo gene delivery' [patent_app_type] => B1 [patent_app_number] => 09/090030 [patent_app_country] => US [patent_app_date] => 1998-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 60 [patent_no_of_words] => 19419 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806084.pdf [firstpage_image] =>[orig_patent_app_number] => 09090030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183766 [patent_doc_number] => 06153184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 9/093145 [patent_app_country] => US [patent_app_date] => 1998-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5608 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153184.pdf [firstpage_image] =>[orig_patent_app_number] => 093145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257789 [patent_doc_number] => 06258596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Variants of apolipoprotein A-I' [patent_app_type] => 1 [patent_app_number] => 8/952796 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 12069 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258596.pdf [firstpage_image] =>[orig_patent_app_number] => 952796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565286 [patent_doc_number] => 06339068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Vectors and methods for immunization or therapeutic protocols' [patent_app_type] => B1 [patent_app_number] => 09/082649 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28714 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339068.pdf [firstpage_image] =>[orig_patent_app_number] => 09082649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1366572 [patent_doc_number] => 06562335 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/077045 [patent_app_country] => US [patent_app_date] => 1998-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3966 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562335.pdf [firstpage_image] =>[orig_patent_app_number] => 09077045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4400511 [patent_doc_number] => 06270795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Method of making microencapsulated DNA for vaccination and gene therapy' [patent_app_type] => 1 [patent_app_number] => 9/079400 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 10074 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270795.pdf [firstpage_image] =>[orig_patent_app_number] => 079400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237319 [patent_doc_number] => 06165990 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Antisense polynucleotide' [patent_app_type] => 1 [patent_app_number] => 9/079372 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 20379 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165990.pdf [firstpage_image] =>[orig_patent_app_number] => 079372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631309 [patent_doc_number] => 06635623 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Lipoproteins as nucleic acid vectors' [patent_app_type] => B1 [patent_app_number] => 09/079030 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 58 [patent_no_of_words] => 59720 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635623.pdf [firstpage_image] =>[orig_patent_app_number] => 09079030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360049 [patent_doc_number] => 06169078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Materials and methods for the intracellular delivery of substances' [patent_app_type] => 1 [patent_app_number] => 9/076468 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7446 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169078.pdf [firstpage_image] =>[orig_patent_app_number] => 076468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534895 [patent_doc_number] => 06489305 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Methods and compositions for the treatment of ocular diseases' [patent_app_type] => B1 [patent_app_number] => 09/075505 [patent_app_country] => US [patent_app_date] => 1998-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11899 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489305.pdf [firstpage_image] =>[orig_patent_app_number] => 09075505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356329 [patent_doc_number] => 06190912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Blk genes and uses thereof in apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/052877 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 11298 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190912.pdf [firstpage_image] =>[orig_patent_app_number] => 052877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493313 [patent_doc_number] => 06342214 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Method for viral vector delivery' [patent_app_type] => B1 [patent_app_number] => 08/952501 [patent_app_country] => US [patent_app_date] => 1998-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5469 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342214.pdf [firstpage_image] =>[orig_patent_app_number] => 08952501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550875 [patent_doc_number] => 06399584 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Pharmaceutical composition containing ezrin mutated on tyrosine 353' [patent_app_type] => B1 [patent_app_number] => 09/040725 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 4976 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399584.pdf [firstpage_image] =>[orig_patent_app_number] => 09040725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349215 [patent_doc_number] => 06284944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring' [patent_app_type] => 1 [patent_app_number] => 9/041185 [patent_app_country] => US [patent_app_date] => 1998-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11788 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284944.pdf [firstpage_image] =>[orig_patent_app_number] => 041185 [rel_patent_id] =>[rel_patent_doc_number] =>)